Evaluation of the Response to Tyrosine Kinase Inhibitors in Localized Non-small Cell Lung Cancer (NSCLC) Patients With EGFR Mutation in a Patient-derived Organoid Model
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Central Hospital, Nancy, France
With
Institut de Cancérologie de Lorraine
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
age 18 years or older
patient affiliated to a social security scheme
having given their agreement to participate in the study
with non small cell lung cancer of any stage undergoing surgical resection at the Nancy University Hospital
You may not be if
Refusal to participate
Hepatitis
HIV
Legal guardianship
Guardianship
Inability to give informed information to the patient
Pregnant women-
Clareo Health | Evaluation of the Response to Tyrosine Kinase Inhibitors in Localized Non-small Cell Lung Cancer (NSCLC) Patients With EGFR Mutation in a Patient-derived Organoid Model
